SCHEMBL20735896

SCHEMBL20735896

CCn1c(-c2ccc(-c3ccc4c5c(ccc4c3)-c3c(c4ccccc4c4ccccc34)C53c4ccccc4-c4ccccc43)cc2)nc2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.44
ALDH1A1 P00352 7/20 0.44
HPGD P15428 4/20 0.44
MAPT P10636 5/20 0.43
NPSR1 Q6W5P4 3/20 0.43
HTT P42858 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
NLRP3 Q96P20 1/20 0.38
TP53 P04637 5/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27250436 0.96 KDM4E (0.41) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20735897 0.93 KDM4E (0.45) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20737106 0.91 KDM4E (0.47) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL27250437 0.89 MAPT (0.48) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20737150 0.89 KDM4E (0.43) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20735895 0.88 KDM4E (0.41) KDM4EALDH1A1HPGDMAPTHTT
SCHEMBL20737702 0.88 KDM4E (0.48) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20735967 0.88 KDM4E (0.35) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL20736332 0.88 KDM4E (0.44) KDM4EALDH1A1HPGDMAPTNPSR1
SCHEMBL17862934 0.87 KDM4E (0.47) KDM4EALDH1A1HPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885ALDH1A1 125/4885HPGD 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.